NETO2 expression based on
CESC : Cervical squamous cell carcinoma *
Please note that low number(<10) of normal samples considered.
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
Comparison Statistical significance Normal-vs-Primary 1.62436730732907E-12
Pan-cancer view
Methylation
Survival
Correlated genes
CESC : Cervical squamous cell carcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 8 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.62436730732907E-12
Normal-vs-Stage2
1.62436730732907E-12
Normal-vs-Stage3
9.86655201984377E-13
Normal-vs-Stage4
1.46959999725027E-10
Stage1-vs-Stage2
9.390000E-01
Stage1-vs-Stage3
5.158000E-01
Stage1-vs-Stage4
5.078000E-02
Stage2-vs-Stage3
5.188600E-01
Stage2-vs-Stage4
6.160100E-02
Stage3-vs-Stage4
3.320000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
CESC : Cervical squamous cell carcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 37 samples. Two samples from Native Hawaiian and seven samples from American Indians are not considered in the above plot.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
<1E-12
Normal-vs-AfricanAmerican
3.76854103478763E-12
Normal-vs-Asian
7.06949999651485E-08
Caucasian-vs-AfricanAmerican
2.333800E-01
Caucasian-vs-Asian
1.478430E-01
AfricanAmerican-vs-Asian
6.928000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
CESC : Cervical squamous cell carcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 46 samples.
Descriptions Normal weight BMI greater than equal to 18.5 and BMI less than 25
Extereme weight
BMI greater than equal to 25 and BMI less than 30 Obese BMI greater than equal to 30 and BMI less than 40
Extreme Obese
BMI greater than 40
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Normal_Weight
<1E-12
Normal-vs-Extreme_Weight
1.62447832963153E-12
Normal-vs-Obese
<1E-12
Normal-vs-Extreme_Obese
1.504610E-03
Normal_Weight-vs-Extreme_Weight
3.110600E-01
Normal_Weight-vs-Obese
2.038000E-02
Normal_Weight-vs-Extreme_Obese
6.097000E-01
Extreme_Weight-vs-Obese
1.984580E-01
Extreme_Weight-vs-Extreme_Obese
4.256600E-01
Obese-vs-Extreme_Obese
2.608000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
CESC : Cervical squamous cell carcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample. One sample from patients below 21 years are not considered in above plot.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
<1E-12
Normal-vs-Age(41-60Yrs)
<1E-12
Normal-vs-Age(61-80Yrs)
<1E-12
Normal-vs-Age(81-100Yrs)
1.552550E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.596800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.748600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.484200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.566000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.558200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.732000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
CESC : Cervical squamous cell carcinoma *
Please note that low number(<10) of normal samples considered.
Note
Histological subtype information is not available for 1 sample.
Subtype descriptions Adenosquamous Cervical adenosquamous carcinoma
Squamous-cell Cervical squamous cell carcinoma Endocervical Endocervical adenocarcinoma of the usual type | Endocervical type of adenocarcinoma
Mucinous Mucinous adenocarcinoma of endocervical type Endometrioid Endometrioid adenocarcinoma of endocervix
Show statistics
Hide statistics
Comparison Statistical significance
Adenosquamous-VS-Squamous-cell
9.057600E-01
Adenosquamous-VS-Endocervical
5.229700E-02
Adenosquamous-VS-Endometrioid
4.596900E-03
Adenosquamous-VS-Mucinous
7.919900E-02
Adenosquamous-VS-Normal
8.047000E-04
Squamous-cell-VS-Endocervical
2.30669999999877E-05
Squamous-cell-VS-Endometrioid
2.18090001613547E-09
Squamous-cell-VS-Mucinous
5.100400E-03
Squamous-cell-VS-Normal
1.62447832963153E-12
Endocervical-VS-Endometrioid
3.316700E-03
Endocervical-VS-Mucinous
8.960200E-01
Endocervical-VS-Normal
1.12789999562324E-08
Endometrioid-VS-Mucinous
1.478290E-02
Endometrioid-VS-Normal
2.832500E-04
Mucinous-VS-Normal
1.54689999999347E-05
Pan-cancer view
Methylation
Survival
Correlated genes
CESC : Cervical squamous cell carcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
2.707200E-01
Grade 1-vs-Grade 3
1.243980E-01
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
3.164200E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
CESC : Cervical squamous cell carcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 46 samples and cancer in nearby lymph nodes cannot be measured (NX) in 66 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.62447832963153E-12
Normal-vs-N1
1.62447832963153E-12
N0-vs-N1
6.214600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
